Yesterday, a bipartisan group of key lawmakers on the House Judiciary Committee joined Rep. George Holding in introducing H.R. 5233, the Trade Secrets Protection Act of 2014, a bill to create a federal civil remedy for trade secret theft.
On July 28, 2014, in the latest securities suit to be filed in the wake of high-profile concerns about ‘high frequency trading,” a plaintiff shareholder filed a securities class action lawsuit in the Southern District of New York against Barclays and certain of its officers relating to the company’s operation of and alleged statements about its “dark pool” private securities trading venue.
A new federal earthquake map shows an increased risk for about half of the United States.
In the cold, sadistic world that is the FMLA, the Department of Labor tells us that ordinary, run-of-the-mill headaches (a/k/a “non-migraine” headaches) are not covered by the FMLA.
For decades, food safety experts have lived with the reality that roughly one-third of foodborne illness outbreak investigations ended without finding the source.
How Two Courts of Appeals Applied the Same Law to Reach Opposite Conclusions About the Affordable Care Act
Last week, two federal courts of appeals–the 4th Circuit and D.C. Circuit–considered whether the IRS reasonably interpreted the Affordable Care Act as allowing the IRS to give tax credits to taxpayers that purchase health insurance through an exchange set up by the federal government.
The Parade of Major Reported Health Data Breaches Surges to 885 – Theft and Loss Dominate the Numbers
The number of large breaches of Protected Health Information (PHI) under HIPAA that have been reported on the so-called “Wall of Shame” (the HHS List) maintained by the U.S. Department of Health and Human Services has jumped by 239 to 885 in less than a year.
Allegations of first-degree custodial sexual misconduct against a Washington County jail employee are only the latest in a long series of cases involving the sex abuse of inmates by jail personnel.
As expected, FedEx appeared in federal district court and entered a plea of not guilty to the charges brought against the company by the Drug Enforcement Administration (“DEA”) and the United States Attorney’s Office for the Northern District of California.